SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 1 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $51,000 | -26.1% | 183,477 | 0.0% | 0.00% | – |
| Q1 2022 | $69,000 | -9.2% | 183,477 | 0.0% | 0.00% | – |
| Q4 2021 | $76,000 | -31.5% | 183,477 | 0.0% | 0.00% | – |
| Q3 2021 | $111,000 | -61.7% | 183,477 | 0.0% | 0.00% | – |
| Q2 2021 | $290,000 | -49.6% | 183,477 | -28.3% | 0.00% | – |
| Q1 2021 | $575,000 | +4.5% | 255,761 | +3.7% | 0.00% | – |
| Q4 2020 | $550,000 | -11.1% | 246,555 | +2.5% | 0.00% | – |
| Q3 2020 | $619,000 | -29.7% | 240,649 | -0.6% | 0.00% | – |
| Q2 2020 | $881,000 | – | 242,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 2,000 | $13,000 | 0.00% |